Emalex Biosciences

1 stories about Emalex Biosciences
המרכז הלוגיסטי של חברת טבע בשוהם

Teva to acquire Emalex in deal worth up to $900 million

29.04.26|Sophie Shulman, CTech
The move strengthens Teva's pipeline with Tourette’s treatment and supports its “Beyond Growth” strategy.